P PRIMESTOCKFINDER.COM

AXE Shares Archer Materials Limited

ACCUMULATE ASX · ASX
$0.18 +0.00% Prices as of close 2026-10-26

Developing graphene-based semiconductor and quantum technologies with substantial upside if partnerships convert into commercial revenue.

Future value: $0.28 (+60.00%) · 6-12 months

  • ▸Technology milestones and partnership announcements could provide near-term catalysts.
  • ▾Below 50-day MA (-5.53%)
  • ▾Near 52-week low (4.3% of range)
  • ▸~60% upside to price target

Trend: AXE is trading below the 50-day average (-2.78%), RSI 52 — neutral momentum, with a 3-month return of -16.67%.

Valuation & quality: Archer Materials Limited trades on PEG 3.99, price-to-book 4.17; fundamentals show net margin -270.5%, return on equity -46.3%, revenue growth 15.3% year on year.

Our screen: ACCUMULATE (score 1) — Developing graphene-based semiconductor and quantum technologies with substantial upside if partnerships convert into commercial revenue.

Computed from end-of-day data; not personal advice.

0.44 0.16 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-08 → 2026-10-26 (AUD). Range 0.16 – 0.44.
Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
-14.30%-3.30%+37.90%-22.50%-29.00%-9.10%-15.00%+0.00%
Market cap
$49.8M
EPS (ttm)
$-0.02
Price / book
4.17
PEG
3.99
Beta
-0.08
Net margin
-270.5%
ROE
-46.3%
Revenue growth
15.3%
Revenue (ttm)
$2.4M
Free cash flow
$-3,197,803
52-wk range
$0.16 – $0.51
Volume
25,275
Avg volume (3m)
403,630
RSI (14)
51.7
vs 50-day MA
-2.78%
1-mo return
+9.38%
3-mo return
-16.67%
Volume z-score
-1.18

Archer Materials Limited operates as a quantum technologies company in Australia. The company develops semiconductor devices, including chips relevant to quantum computing, sensing, and medical diagnostics.

Sector: Technology · Industry: Semiconductors · Australia · Website

Browse: all ASX stocks · Semiconductors picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.